Electrochemotherapy for internal organ tumors
Part of Cancer, Digestive system, Infections, Skin clinical trials.
This trial tests a treatment called electrochemotherapy for tumors in internal organs (like the liver or pancreas) when standard treatments are no longer possible. It uses a drug called bleomycin plus electric pulses to target cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can understand and agree to the treatment plan.
- You have a tumor in an internal organ (like the liver, pancreas, or kidney), either from a first-time cancer or from another cancer that has spread.
- Standard treatments like surgery, chemotherapy, or radiation are not an option for you.
- You do not have cancer that has spread to your brain, lungs, or bones.
- You are not allergic to the drug bleomycin, and you do not have serious lung problems or a lung infection.
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if electrochemotherapy can change the environment around melanoma tumors. It may help patients with melanoma that has spread to the skin or just under the skin.
This trial tests two procedures—irreversible electroporation and stereotactic body radiotherapy—for people whose colorectal cancer has spread to the liver (1–3 tumors near major blood vessels or bile ducts) and can't be surgically removed or treated with heat. The goal is to see if these approaches can safely destroy those hard-to-reach tumors.
This Phase 2 study compares adding electrotherapy to give carboplatin plus bleomycin directly to the tumor versus giving bleomycin alone. It may help shrink recurrent vulvar cancer when standard options aren’t suitable and your health is limited.
This trial studies different ways to place treatments inside the liver to control liver tumors when they can’t be removed with surgery or ablation. It may help certain people by improving how well the tumor is treated while keeping liver function safer.
This trial tests if a lower dose of the drug bleomycin works as well in electrochemotherapy for skin or under-the-skin tumors. The goal is to reduce side effects while still treating cancer effectively.
This Phase 2 study tests electrotherapy (a way to help treatment reach tumor cells) for gynecologic cancers that have come back after standard treatments were used up. You may be considered if your overall health allows anesthesia and if certain cancer spread and medical safety issues do not apply.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.